ATM Yusuf | Phytochemistry | Best Researcher Award

Published on by Cell Biologist

Mr. ATM Yusuf | Phytochemistry | Best Researcher Award

Mr. ATM Yusuf  , University of Science and Technology Chittagong , Bangladesh

ATM Yusuf is an Assistant Professor in the Department of Pharmacy at the University of Science and Technology Chittagong (USTC), Bangladesh. He has extensive experience in teaching, research, and academia, with a focus on pharmacology and clinical pharmacy. Yusuf holds a Master of Pharmacy degree in Pharmacology and Clinical Pharmacy from North South University and a Bachelor of Pharmacy from the International Islamic University Chittagong. With a career spanning several academic institutions, he has contributed to a range of scientific studies and publications, particularly in the fields of medicinal plant pharmacology and pharmaceutical sciences. Yusuf is passionate about enhancing drug development through innovative research and has been an active participant in national and international academic communities.

Publication Profile:

Google Scholar

Strengths for the Award:

ATM Yusuf has demonstrated an outstanding commitment to advancing the field of pharmaceutical sciences. His research on medicinal plants, drug formulations, and pharmacology showcases his expertise and passion for improving health outcomes. He has a proven track record of publishing in prestigious journals, contributing significantly to the understanding of pharmacological properties of natural compounds, and has received substantial grants for his research. Furthermore, Yusuf’s teaching and mentoring in the Department of Pharmacy at USTC emphasize his dedication to both education and research. His interdisciplinary approach, combining in vivo and computational investigations, highlights his scientific versatility and the potential for groundbreaking discoveries in pharmaceutical sciences.

Areas for Improvement:

While Yusuf’s research contributions are notable, there is room for further expansion into clinical studies to complement his preclinical findings. In particular, increasing collaboration with clinical practitioners could provide practical applications for his pharmacological studies and broaden his research impact.

Education:

ATM Yusuf completed his Master of Pharmacy (M. Pharm) in Pharmacology and Clinical Pharmacy from North South University, Dhaka, in 2014. Prior to that, he earned his Bachelor of Pharmacy (B. Pharm) from the International Islamic University Chittagong in 2012. His foundational education in pharmacy was complemented by advanced studies in pharmacology, clinical pharmacy, and medicinal chemistry, which provided him with a strong academic grounding in drug development and therapeutic solutions. Yusuf also completed his Higher Secondary Certificate (H.S.C.) in 2007 from BN School and College in Chittagong and his Secondary School Certificate (S.S.C.) in 2005 from BEPZA Public School and College, Chittagong. His academic journey reflects a consistent commitment to pharmaceutical sciences, research, and education.

Experience:

ATM Yusuf has a broad academic background, currently serving as an Assistant Professor in the Department of Pharmacy at the University of Science and Technology Chittagong (USTC) since February 2022. Before this, he held the position of Lecturer at USTC (2018-2022) and at Ranada Prasad Shaha University (2017-2018). His experience spans both teaching and research, where he has taught a wide range of pharmacy-related subjects, contributing to the development of future pharmacists. In addition to his academic roles, he has served as the Assistant Proctor at USTC since December 2023, overseeing student affairs and academic integrity. Yusuf has also been involved in numerous research projects, focusing on medicinal plants, pharmacology, and drug formulation. His professional journey has been marked by a dedication to advancing pharmacy education, fostering student success, and producing high-impact research in pharmaceutical sciences.

Awards and Honors:

ATM Yusuf has earned recognition for his academic and research achievements. One notable honor is the 75% scholarship awarded to him throughout all semesters during his undergraduate studies at the International Islamic University Chittagong, reflecting his academic excellence. This scholarship highlights his commitment to academic achievement and sets a foundation for his future research endeavors. In addition to his scholarship, Yusuf has been awarded research grants, including the R&D Research Grant 2022-2023 from the Ministry of Science and Technology, Bangladesh, and the USTC Research Cell (URC) Grant in 2022. These grants support his continued research in pharmacology, medicinal plants, and drug development. His dedication to advancing knowledge in the field of pharmacy is evident in the recognition he has received from both educational institutions and research organizations.

Research Focus:

ATM Yusuf’s research primarily revolves around pharmacology, medicinal plants, and the development of novel drug formulations. He has focused on investigating the phytochemistry and pharmacology of various plant species, exploring their potential therapeutic applications. Yusuf’s studies on Delonix regia, Ganoderma lucidum, and Citrus maxima exemplify his commitment to studying the medicinal properties of plants and their roles in treating diseases. His research also spans computational and in vivo investigations, aimed at understanding the biochemical and pharmacological effects of natural compounds. Additionally, Yusuf has explored drug formulation strategies, such as solid dispersions to enhance the dissolution rate of poorly soluble drugs like Ketoprofen. Through his research, he aims to bridge the gap between traditional medicine and modern pharmacological practices, contributing valuable knowledge to the field of pharmaceutical sciences and drug development.

Publication Top Notes:

  1. In-Vitro Cytotoxic and Thrombolytic Potential of Pothos scandens L. 💊🌿
  2. In vitro Anti-arthritic and Thrombolytic activities of Protium serratum L. 💪💉
  3. Evaluation of cytotoxic and thrombolytic activities of Sida acuta. 🧬💥
  4. Glucosidase Inhibitory Effects of Unani, Ayurvedic, and Homeopathic medicines. 🌱💊
  5. Non-clinical evaluation of antioxidant and anti-inflammatory activity of Citrus maxima peel extract. 🍊💪
  6. Protective and toxicogenetic aspects of Piper betle. 🍃🔬
  7. Improvement of Dissolution Rate of Ketoprofen Using Solid Dispersions. 💊🔬
  8. Phytochemical and the Antibacterial, Antifungal, and Cytotoxic Activities of Alstonia scholaris. 🍃💉
  9. Investigation of Ceftibuten with Antacid and Metal Interaction. 💊⚖️
  10. Profiling of phytochemicals and antioxidant activity of wild mushrooms. 🍄🧪

Conclusion:

ATM Yusuf is a promising candidate for the Research for Best Researcher Award. His academic achievements, research output, and dedication to advancing pharmaceutical sciences make him a highly suitable choice. With ongoing growth in clinical research, Yusuf has the potential to make even greater contributions to the field. His work continues to inspire both students and colleagues alike, and his leadership in research will likely yield even more impactful results in the future.

 

 

 

Ayrton Bangolo | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Ayrton Bangolo | Cancer Cell Biology | Best Researcher Award

Dr. Ayrton Bangolo , Hackensack University Medical Center , United States

Ayrton I. Bangolo, MD, is an accomplished board-certified Internal Medicine physician specializing in Hematology and Oncology. He completed his MBBS (equivalent to MD) from Tianjin Medical University, China, in 2016 and is currently a Hematology and Oncology fellow at Hackensack University Medical Center, NJ. With an impressive record of research publications and contributions to several medical journals, he has a passion for advancing cancer care and the clinical aspects of various diseases. Dr. Bangolo is deeply involved in both clinical practice and research, having worked in multiple specialties and international medical settings. His expertise is enriched by his diverse experiences across different clinical environments, from hospitals in the United States to clinics in the Democratic Republic of the Congo. He holds a variety of leadership roles, demonstrating commitment to the global advancement of healthcare.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Ayrton I. Bangolo’s exceptional contributions to the medical field make him a strong candidate for the “Best Researcher Award.” His work spans critical areas of oncology, including the impact of tumor stage and histopathology on survival outcomes in esophageal cancer, as well as his pioneering research on the gut microbiome’s role in pancreatic cancer treatment. His academic rigor is evident through his prolific research output and successful collaboration with international researchers. Additionally, Dr. Bangolo’s role as a peer reviewer for prominent medical journals underscores his expertise and respect in the medical community. His focus on racial, ethnic, and socioeconomic disparities in cancer care reflects his commitment to improving healthcare outcomes for underserved populations. Moreover, his ongoing research aims to bridge knowledge gaps in critical areas such as thyroid cancer management and gastrointestinal malignancies.

Areas for Improvement:

While Dr. Bangolo’s work is impressive, expanding his collaborative efforts to include more interdisciplinary research could enhance his scope even further. Although his focus on cancer disparities is commendable, there may be opportunities to expand his research into other areas of healthcare equity, such as mental health in cancer patients or global access to cancer treatments. Additionally, increasing involvement in clinical trials may provide real-world validation for his findings, leading to more practical applications in patient care.

Education:

Dr. Bangolo obtained his MBBS from Tianjin Medical University, Tianjin, China, in 2016, and has earned multiple certifications in the United States, including the ECFMG certification. He has successfully completed the USMLE exams, passing all steps (1, 2, and 3) on the first attempt. Dr. Bangolo is currently undergoing advanced training in Hematology and Oncology at Hackensack University Medical Center, NJ, in an ACGME-accredited fellowship program. His prior residency in Internal Medicine and a transitional year at Palisades Medical Center, North Bergen, NJ, has further honed his skills. Throughout his education, Dr. Bangolo has consistently demonstrated academic excellence and a commitment to evidence-based practice. His journey through diverse healthcare systems and international medical education reflects his dedication to global health improvement and patient-centered care.

Experience:

Dr. Bangolo has extensive clinical experience spanning multiple specialties, beginning with his externship and observership roles in Endocrinology, Nephrology, and Interventional Radiology. He served at Endocrine Associates in Louisville, KY, and worked with Dr. Hisham Alrefai in Endocrinology and Dr. Mohammed El Kheir in Nephrology. His residency in Internal Medicine at Palisades Medical Center, North Bergen, NJ, allowed him to build foundational skills in patient care and management across various medical conditions. Currently, he is completing an ACGME-accredited fellowship in Hematology and Oncology at Hackensack University Medical Center, where he continues to refine his expertise in treating complex cancer patients. Additionally, Dr. Bangolo has contributed to clinical research and presented at various academic conferences. His exposure to diverse medical environments, from the US to the Democratic Republic of the Congo, gives him a well-rounded perspective on healthcare delivery.

Awards and Honors:

Dr. Bangolo has received numerous awards and accolades, highlighting his outstanding contributions to the medical field. Among his notable recognitions is the 2nd Place for his original research poster on “Racial/Ethnic and Socioeconomic Differences in Colon Cancer Surgery Performed” during the HMH North Region Fellow/Residents Research Day. He was also involved in publishing open-access articles on significant public health issues, including the United Nations Sustainable Development Goals related to cancer treatment disparities. Dr. Bangolo’s work on ultrasound performance in the diagnosis of thyroid cancer earned recognition in the scientific community. His publications have made significant impacts, including in journals such as Breast Cancer Research and Treatment and World Journal of Gastroenterology. His consistent dedication to advancing medical knowledge, addressing healthcare disparities, and improving treatment outcomes has made him a respected figure in his field.

Research Focus:

Dr. Bangolo’s research primarily focuses on oncology, with a particular emphasis on cancer disparities, treatment outcomes, and innovative diagnostic methods. He has extensively studied the impacts of tumor stage and histopathology on survival outcomes in esophageal cancer and the influence of primary percutaneous coronary intervention on myocardial infarction outcomes. His work also includes investigating trends in thyroid cancer incidence, improving the understanding of gastrointestinal cancers, and exploring the role of the microbiome in pancreatic cancer. Dr. Bangolo is dedicated to researching the epidemiological factors that influence cancer outcomes in underserved populations, with a particular interest in racial, ethnic, and socioeconomic differences in treatment and survival. His ongoing research aims to improve treatment protocols and contribute to global cancer care, especially in resource-limited settings like the Democratic Republic of the Congo, where he has firsthand experience working.

Publications Top Notes:

  1. The Impact of Tumor Stage and Histopathology on Survival Outcomes in Esophageal Cancer Patients 📑
  2. Comprehensive Analysis of the Impact of Primary Percutaneous Coronary Intervention on Patients with ST-Segment Elevation Myocardial Infarction 💓
  3. Impact of American Thyroid Association’s Revised Cancer Management Guidelines on Thyroid Cancer Incidence Trends 📊
  4. Racial/Ethnic and Socioeconomic Differences in Colon Cancer Surgery Performed and Delayed Surgical Treatment 🎗️
  5. Ultrasound Performance Using the EU-TIRADS Score in the Diagnosis of Thyroid Cancer 🩺
  6. Epidemiologic Risk Factors for Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma 🦠
  7. Impact of Gut Microbiome in the Development and Treatment of Pancreatic Cancer 🧬
  8. Primary Cardiac Sarcoma: Clinical Characteristics and Prognostic Factors ❤️
  9. The Overall Quality of Evidence of Recommendations Surrounding Nutrition and Diet in Inflammatory Bowel Disease 🥗
  10. Outcomes of Patients with Gastrointestinal Stromal Tumors in the Past Decade 💉

Conclusion:

Dr. Ayrton I. Bangolo is undoubtedly a leading researcher in the field of oncology, with a robust academic and clinical background, significant contributions to medical literature, and a passion for addressing global healthcare disparities. His dedication to understanding complex diseases, combined with his focus on improving patient outcomes, positions him as a deserving candidate for the “Best Researcher Award.” Expanding his research to incorporate broader interdisciplinary efforts and clinical trials would further elevate his impact.

 

 

 

Salam Bani Hani | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Dr. Salam Bani Hani | Cell Structure Analysis | Best Researcher Award

Dr. Salam Bani Hani , Irbid National University , Jordan

Dr. Salam Bani Hani is an Assistant Professor and Head of the Nursing Department at Irbid National University, Jordan. She holds a PhD in Nursing Philosophy from the University of Jordan, where she earned a perfect GPA of 4/4. She also holds an MSc in Nursing Service Administration from Jordan University of Science and Technology and a BSN from Al-Al Bayt University. Dr. Bani Hani has a strong academic background, and her research primarily focuses on nursing documentation, healthcare data, and predictive models in healthcare. In addition to her academic role, she has extensive clinical experience, having worked as a patient and family educator in Qatar and a clinical instructor at Al-Al Bayt University. She has made significant contributions to nursing education and research, publishing numerous studies in international journals and presenting at conferences globally. Her expertise bridges clinical practice and academic advancement.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Salam Bani Hani demonstrates remarkable expertise in nursing research, with a clear focus on the integration of technology and data analytics in healthcare. Her work on using large-scale data to predict ischemic heart disease and her contributions to nursing documentation through comparative studies of paper-based and electronic health records reflect her ability to tackle relevant, contemporary issues in healthcare. Her research has been widely published in respected journals, with numerous articles on topics such as digital health literacy, the use of artificial intelligence in healthcare, and predicting mortality in heart disease patients. Her academic excellence, reflected in her perfect PhD GPA, coupled with her extensive teaching experience, makes her an exemplary candidate for this award.

Areas for Improvement:

While Dr. Bani Hani’s academic and clinical achievements are impressive, further engagement in collaborative, interdisciplinary research could enhance the impact of her work. Additionally, expanding her outreach through international conferences and workshops could elevate her profile even further.

Education:

Dr. Salam Bani Hani holds a PhD in Nursing Philosophy from the University of Jordan (2019–2022), graduating with an exceptional GPA of 4/4. Her dissertation focused on predicting ischemic heart disease in the Jordanian population using large-scale data. She also holds a Master of Science in Nursing (MSc) in Nursing Service Administration from Jordan University of Science and Technology, where she received a GPA of 94.1. Her thesis explored the quality of nursing documentation, comparing paper-based and electronic health records. She completed her Bachelor of Science in Nursing (BSN) at Al-Al Bayt University in 2011 with an excellent GPA of 88.7. Dr. Bani Hani’s academic achievements are complemented by various specialized training courses, including life support, pain management, and simulation education, all of which contribute to her comprehensive expertise in nursing and healthcare.

Experience:

Dr. Salam Bani Hani currently serves as an Assistant Professor and Head of the Nursing Department at Irbid National University, Jordan. She has been in this role since November 2023. Previously, she was a Clinical Instructor at Al-Al Bayt University, teaching across various nursing fields such as medical-surgical, emergency, and critical care. She has also served as a Patient and Family Educator at Hamad Medical City, Qatar, from 2018 to 2019. Dr. Bani Hani started her clinical career as a Staff Nurse in the emergency ward at Jordan University Hospital, one of the leading hospitals in the Middle East. She has extensive experience in both clinical practice and teaching, specializing in nursing education, patient care, and healthcare management. Additionally, she actively participates in various professional development programs and workshops, contributing significantly to both academia and practice in the nursing field.

Awards and Honors:

Dr. Salam Bani Hani has received numerous accolades in recognition of her academic and professional achievements. She earned the highest honors in her PhD studies, graduating with a perfect GPA of 4/4 from the University of Jordan. Throughout her career, she has contributed to advancing nursing education and practice, and her work has been published in several prestigious journals. Additionally, she has been involved in organizing and attending key nursing conferences, including the 2nd International Nursing Conference in 2023. Dr. Bani Hani’s work in the realm of healthcare data analysis, digital health, and nursing documentation has earned her recognition in both academic and clinical settings. Her dedication to improving healthcare delivery through research and education has been recognized by peers and institutions, positioning her as a leader in the nursing profession. She has also contributed significantly to nursing education through various workshops and specialized training programs.

Research Focus:

Dr. Salam Bani Hani’s research focuses on the intersection of nursing education, digital health, and predictive healthcare models. Her PhD dissertation explored the use of large-scale data to predict ischemic heart disease among the Jordanian population, which aligns with her research interest in healthcare data analytics. She has extensively researched nursing documentation, comparing paper-based versus electronic health records, and has contributed to advancing the field of digital health literacy. Dr. Bani Hani is particularly interested in the application of artificial intelligence (AI) and machine learning in healthcare, with research that investigates how AI can be used to improve patient care and support healthcare decision-making. Her work also delves into the competencies required for oncology nurses and the role of technology in improving clinical practices. Additionally, she has explored the impact of COVID-19 on nursing practices and is actively involved in enhancing nursing education through blended learning and interactive training.

Publications Top Notes:

  • Quality of nursing documentation: Paper‐based health records versus electronic‐based health records 📚
  • Machine-learning algorithms for ischemic heart disease prediction: a systematic review 💻
  • Attitudes of Jordanian Oncology Nurses Toward Computerization 📊
  • Electronic health literacy and its association with lifestyle behavior among undergraduate students 💡
  • Assessment of genetic variation among Jordanian barley landraces (Hordeum vulgare L.) 🌾
  • Large-scale data in health care: a concept analysis 🏥
  • Transforming cancer clinical trials: The integral role of artificial intelligence in electronic health records 🤖
  • Effective prediction of mortality by heart disease among women in Jordan using the chi-squared automatic interaction detection model 🩺
  • Effectiveness of blended learning basic life support module on knowledge and skills: A systematic review of randomized controlled trials 💡
  • Assessing digital health literacy level among nurses in Jordanian hospitals 🏥

Conclusion:

Dr. Salam Bani Hani is highly deserving of the Research for Best Researcher Award. Her consistent contributions to advancing nursing practice, her innovative use of technology in healthcare, and her rigorous academic achievements reflect her commitment to improving patient care and nursing education. With her comprehensive skill set and dedication, she continues to make significant strides in both clinical and academic research, positioning her as a leader in her field.

 

 

 

Ndèye Aby NDOYE | Cell Differentiation Processes | Women Researcher Award

Published on by Cell Biologist

Prof. Ndèye Aby NDOYE | Cell Differentiation Processes | Women Researcher Award

Prof. Ndèye Aby NDOYE , Faculty of Medicine, Cheikh Anta Diop University, Senegal , Senegal

Prof. .Ndèye Aby NDOYE is a dedicated pediatric surgeon from Senegal, specializing in disorders of sexual development (DSDs) and pediatric surgical interventions. With a deep commitment to improving child health, she has contributed significantly to research in pediatric surgery, focusing on the diagnosis and treatment of rare conditions. Her work aims to enhance surgical outcomes and patient care in the African context. prof. Ndèye Aby NDOYE has presented at numerous medical conferences, collaborated with international experts, and worked extensively within Senegal’s leading medical institutions. Passionate about advancing pediatric healthcare, she is driven by the goal of making specialized medical services more accessible to children in sub-Saharan Africa.

Publication Profile:

Scopus

Strengths for the Award:

  1. Strong Research Output: The individual has contributed significantly to the research in pediatric surgery, specifically in disorders of sexual development (DSDs) and related conditions, showing a diverse range of publications. Their work is essential for advancing medical knowledge in these rare and complex conditions.
  2. Focus on Underrepresented Issues: The research primarily focuses on pediatric DSDs and congenital conditions in sub-Saharan Africa, which is an underrepresented and crucial area of study. By addressing these unique healthcare challenges, the researcher is contributing to medical knowledge that can significantly impact pediatric surgery outcomes in low-resource settings.
  3. Multidisciplinary Approach: The research covers a wide spectrum of topics, from the diagnostic aspects of congenital malformations to the management of complex surgeries, which showcases the individual’s broad expertise in pediatric healthcare.
  4. Commitment to Healthcare in Africa: Working in Senegal and contributing to the improvement of pediatric care in the region, the researcher is addressing both medical and infrastructural challenges in sub-Saharan Africa, an area where access to specialized care is limited. Their work is instrumental in enhancing local healthcare practices.
  5. Patient-Centered Approach: The research takes into account both the clinical and psychological impacts of these conditions, focusing on gender reassignment, the surgical outcomes, and post-operative recovery, particularly in the context of pediatric patients.

Areas for Improvement:

  1. Collaboration & Visibility: While the researcher has contributed to multiple articles, further collaboration with international researchers or institutions could potentially elevate the visibility and impact of their work. Engaging in more global research networks might allow for better knowledge dissemination.
  2. Long-Term Impact Measurement: The research could benefit from more longitudinal studies that follow up on patients long-term to track the evolution of outcomes after surgeries like gonadectomy and genitoplasty. This could provide more comprehensive insights into the long-term implications of the surgeries and improve patient care further.
  3. Expanding Research Focus: Although the researcher has made substantial contributions to understanding pediatric DSDs, expanding the research to explore other related areas such as genetic research or advanced surgical techniques might provide a more holistic approach to treating pediatric conditions.

Education (150 words):

Prof. Ndèye Aby NDOYE obtained her medical degree from the University of Faculty of Medicine, Cheikh Anta Diop University, Senegal, followed by specialized training in pediatric surgery at Faculty of Medicine, Cheikh Anta Diop University, Senegal. She pursued further fellowship studies in pediatric surgical subspecialties, focusing on complex congenital anomalies. Prof. Ndèye Aby NDOYE also completed advanced studies in the diagnosis and management of disorders of sexual development (DSDs), receiving mentorship from renowned pediatric surgeons internationally. She is committed to continuous learning, having attended several international workshops and seminars on pediatric surgery, genetics, and child health. Her academic journey has been marked by a passion for clinical excellence and a drive to bring innovative solutions to pediatric care in Africa.

Experience (150 words):

Prof. Ndèye Aby NDOYE has extensive clinical experience in pediatric surgery, having worked at the Albert Royer National Children’s Hospital Center in Dakar, one of the leading institutions in Senegal. She has managed a variety of complex cases, including ovotesticular DSDs, congenital diaphragmatic hernia, and gastrointestinal malformations. Her clinical expertise spans diagnostics, surgical interventions, and post-operative care for children with rare and complex medical conditions. Prof. Ndèye Aby NDOYE has been instrumental in improving clinical protocols and patient management within the department. Her collaborative approach with local and international teams has led to several research initiatives aimed at improving pediatric surgical outcomes in Africa. Her work has contributed to advancing knowledge on pediatric conditions, while also advocating for better medical infrastructure and resources to support children’s healthcare in sub-Saharan Africa.

Research Focus (150 words):

Prof. Ndèye Aby NDOYE research primarily focuses on disorders of sexual development (DSDs) in pediatric patients, aiming to improve diagnostic methods, treatment approaches, and long-term outcomes. She is particularly interested in ovotesticular DSDs and gender reassignment in pediatric surgery. Her work includes investigating genetic, hormonal, and surgical aspects of these conditions, while considering cultural, ethical, and regional challenges. Prof. Ndèye Aby NDOYE also studies the epidemiology and management of pediatric congenital anomalies in sub-Saharan Africa, emphasizing the need for accurate diagnosis and timely surgical intervention. Additionally, her research explores pediatric surgical outcomes, with an interest in identifying risk factors and improving post-operative care for children undergoing complex surgeries. By focusing on improving access to quality healthcare in Africa, Prof. Ndèye Aby NDOYE seeks to bring more attention to the unique medical needs of children in low-resource settings.

Publications (Titles with Emojis):

  1. “Ileal Perforation Peritonitis Secondary to Ingestion of Magnetic Beads in the Older Child: A Case Report” 🧠🍽️
  2. “Intravaginal Foreign Body: A Rare Cause of Persistent Vaginal Discharge in a Child” 🩺🚼
  3. “Telomere Dysfunction in Pediatric Patients with Differences/Disorders of Sexual Development” 🔬🧬
  4. “Factors Associated with Mortality in Congenital Malformations of the Gastrointestinal Tract in a Tertiary Center in Senegal” 💀🩻
  5. “Pediatric Umbilical Hernia: Is Repair with Continuous Suture Safe?” 🤔🔩
  6. “Conservative Management of Urethral Prolapse in African Girls: A Report of 15 Cases” 💡🩺
  7. “Management of Congenital Diaphragmatic Hernia in Sub-Saharan Africa: Experience in the Albert Royer National Children’s Hospital Center, Senegal” 🌍👶
  8. “Choledochal Cyst in Children in Dakar: Diagnostic and Therapeutic Aspects” 🏥🔍
  9. “Meckel’s Diverticulitis by Ascaris in Children: About a Case” 🐛🩺
  10. “Omphalomesenteric Fistulas: Epidemiological Diagnostic and Therapeutic Features” ⚠️👶

Conclusion:

The individual is highly suitable for the Research for Women Researcher Award due to their impactful contributions to pediatric surgery research, particularly in the challenging context of sub-Saharan Africa. Their work addresses critical health issues related to sexual development disorders and congenital conditions, significantly enhancing medical care and understanding in an underrepresented field. With some improvements in global collaboration and expanding their research focus, they can further solidify their impact on global pediatric health.

 

 

 

Paola Cynthia Demeni Emoh | Endophytic fungi | Young Scientist Award

Published on by Cell Biologist

Mrs. Paola Cynthia Demeni Emoh | Endophytic fungi | Young Scientist Award

Mrs. Paola Cynthia Demeni Emoh , University of Yaoundé 1 , Cameroon

Cynthia Paola Demeni Emoh is a Ph.D. candidate in Medical Microbiology at the University of Yaoundé I, Cameroon. She has a keen interest in the antimicrobial properties of natural products and their potential applications in treating infectious diseases like malaria and pneumonia. Cynthia also serves as a part-time lecturer, teaching microbiology practicals at her university. She is an active researcher and has contributed to multiple systematic reviews and meta-analyses, focusing on infectious diseases. Her collaborations with international networks, such as the AGNES and YaBiNaPA programs, have expanded her research reach. Cynthia is also a member of the American Society of Microbiology and a contributor to various scientific journals. With her solid academic background and dedication to scientific advancement, Cynthia continues to strive for excellence in both her research and teaching roles.

Publication Profile:

Orcid

Strengths for the Award:

Cynthia Paola Demeni Emoh is an outstanding candidate for the Research for Young Scientist Award due to her extensive academic background, innovative research, and significant contributions to microbiology. Her work on endophytic fungi and infectious diseases, particularly malaria, demonstrates her commitment to addressing public health challenges in sub-Saharan Africa. Her experience with systematic reviews and meta-analyses further highlights her expertise in synthesizing global data to drive scientific advancements.

Areas for Improvement:

While Cynthia has established a strong foundation in microbiology, she could benefit from additional experience in interdisciplinary research, particularly in translational science. Collaborations with clinicians or public health experts could broaden her research’s practical applications and improve its potential for real-world impact.

Education:

Cynthia’s educational journey began at the University of Yaoundé I, where she earned her Bachelor’s degree in Microbiology in 2016. She later pursued a Master’s degree in Medical Microbiology at the same institution, which she completed in 2019. During her master’s program, she focused on assessing the antibacterial properties of endophytic fungi isolated from Alstonia boonei and Greenwayodendron suaveolens, particularly their effectiveness against pneumonia bacteria. Building on her master’s research, Cynthia is now a Ph.D. candidate in Medical Microbiology at the University of Yaoundé I. Her Ph.D. research, initiated in 2020, examines the antiplasmodial activity of endophytic fungi extracts from Alstonia boonei and their modes of action. Cynthia’s academic trajectory is shaped by a solid foundation in microbiology, driven by her interest in infectious diseases and their treatment. She has also earned a Baccalaureate in Life Sciences from François Xavier Vogt College in Yaoundé.

Experience:

Cynthia’s professional experience spans both teaching and research in microbiology. She has been a part-time lecturer at the University of Yaoundé I since October 2018, where she is responsible for the practical component of microbiology courses. She has also contributed significantly as an assistant researcher at the Biotechnology Centre of the University of Yaoundé I in 2019, where she worked on phytopathology. Cynthia’s research experience extends beyond Cameroon, having completed an internship at the University of Abomey-Calavi in Benin in 2023, focusing on applied microbiology and pharmacology. Additionally, she interned at the Centre Pasteur of Cameroon in 2022 and 2023, contributing to malaria research. She has been a member of various research groups, including the Systematic Reviews and Meta-Analysis team led by Dr. Kenmoe Sebastien at the Centre Pasteur of Cameroon. Cynthia’s research output and collaborations have strengthened her expertise in microbiology, especially in the areas of infectious diseases and natural products.

Research Focus:

Cynthia’s research focuses on investigating the antimicrobial properties of endophytic fungi extracts, with particular emphasis on their antiplasmodial and antibacterial activities. Her Ph.D. research centers on the antiplasmodial effects of fungi isolated from Alstonia boonei, a plant known for its medicinal properties. She explores how these fungal extracts can serve as alternative treatments for malaria by assessing their activity against Plasmodium falciparum. Cynthia’s earlier work, during her Master’s program, also centered on the antibacterial properties of endophytic fungi from Alstonia boonei and Greenwayodendron suaveolens and their ability to combat pneumonia bacteria. In addition to her laboratory studies, she has contributed to systematic reviews and meta-analyses, analyzing the prevalence, risk factors, and epidemiology of various infectious diseases, such as hepatitis, tuberculosis, and Crimean-Congo hemorrhagic fever. Cynthia’s research is driven by the need for novel antimicrobial agents, especially against drug-resistant pathogens and emerging diseases in sub-Saharan Africa.

Publication Top Notes:

  1. Assessment of the antiplasmodial and cytotoxicity effects of ethyl acetate extracts against Plasmodium falciparum strains (2025) 🦠🧪
  2. Morphological and molecular characterization of endophytic fungi isolated from Alstonia boonei De Wild (2025) 🔬🍄
  3. Stage-Dependent Release of Plasmodium Falciparum Homolog of T-Cell Immunomodulatory Protein and Suppression of Macrophage-Inflammatory Protein-1 (2025) 🦠💉
  4. Isolation, identification of endophytic fungi from Codiaeum variegatum and assessment of anti-amoebic and anti-inflammatory potential (2024) 🍄🌱
  5. Systematic review with meta-analysis of the global host range of Mycobacterium ulcerans (2024) 🌍🦠
  6. Hepatitis B, C, and D virus infections and risk of hepatocellular carcinoma in Africa (2022) 🦠🌍
  7. Global prevalence and case fatality rate of Enterovirus D68 infections (2022) 🌍🦠
  8. Systematic review of Crimean-Congo Hemorrhagic Fever Virus epidemiology in humans and animals (2021) 🩸🦠
  9. Worldwide epidemiology of Lassa virus in humans and rodents (2020) 🌍🦠
  10. Influence of confounding factors on associations between viral LRTI and subsequent wheezing development (2021) 🧳👶

Conclusion:

Cynthia is a promising young researcher with a clear focus on addressing critical health issues. Her dedication to advancing scientific knowledge, particularly in the fight against infectious diseases, makes her an excellent candidate for the Research for Young Scientist Award.

 

 

 

Romain Villéger | Host-bacteria interactions | Cell Metabolism Award

Published on by Cell Biologist

Assist. Prof. Dr. Romain Villéger | Host-bacteria interactions | Cell Metabolism Award

Assist. Prof. Dr. Romain Villéger , Université de Poitiers , France

Dr. Romain Villéger is an Assistant Professor at the University of Poitiers, France, in the Ecology & Biology of Interactions (EBI) lab, within the Microorganisms-Hosts-Environments (MHE) team. With a Ph.D. from the University of Limoges, his work explores the intricate interactions between probiotics and host cells. He has held postdoctoral positions at the University of Bordeaux and the University of Texas Medical Branch, USA, focusing on microbiota-host relationships and metabolomics. Dr. Villéger’s research aims to unravel the role of bacterial interactions, particularly in the context of gastrointestinal health, microbiota, and cancer. His research has led to significant advancements in understanding microbial pathogenesis, including the effects of probiotics and endocrine disruptors on host cell metabolism. A dedicated researcher, he has contributed to numerous scientific publications and currently leads several high-impact projects on bacteria-host interactions.

Publication Profile:

Scopus

Strengths for the Award:

  1. Expertise in Metabolomics: Dr. Romain Villéger’s extensive work in metabolomics, especially in the context of host-bacteria interactions, positions him as a strong candidate for the Cell Metabolism Award. His research on bacterial influence on host cellular metabolism and gut microbiota interactions contributes significantly to the field of cellular metabolism.
  2. Innovative Research Contributions: His research, particularly on the metabolic changes during amoeba-Legionella interactions, showcases a novel approach to understanding microbial pathogenesis. By identifying metabolic vulnerabilities in pathogens, his work has the potential for therapeutic applications, thus addressing fundamental questions in cell metabolism.
  3. Multidisciplinary Approach: Dr. Villéger combines microbiology, immunology, and metabolomics, which enriches his contributions to cellular metabolism. His research is collaborative, evidenced by numerous projects across different institutions and fields, indicating a broad and innovative approach to the subject.
  4. Publications and Impact: He has a strong publication record, with numerous articles in peer-reviewed journals (19 publications), with high visibility in top-tier journals such as British Journal of Cancer, Frontiers in Cellular and Infection Microbiology, and Environmental Microbiology Reports. This demonstrates his influence and impact in the scientific community.
  5. Research Leadership: As the principal investigator of multiple projects, including those on the effects of phthalates on gut microbiota and cancer development, Dr. Villéger has demonstrated leadership in advancing scientific knowledge in areas that intersect with cell metabolism, host-microbe interactions, and metabolic changes in disease.

Areas for Improvement:

  1. Broader Clinical Translation: While his research shows deep insights into fundamental mechanisms, further work on translating these findings into practical clinical applications or therapeutic interventions would strengthen his impact in applied cellular metabolism.
  2. Interdisciplinary Team Development: While Dr. Villéger collaborates with many renowned researchers, fostering additional interdisciplinary partnerships could enrich his research by incorporating diverse techniques and perspectives from fields like drug development or personalized medicine.
  3. Expanding Metabolomic Toolkits: His research could benefit from exploring emerging and cutting-edge techniques in metabolomics, like single-cell analysis or multi-omics approaches, to gain deeper insights into cellular metabolism at the individual cell level.

Education:

Dr. Villéger completed his Ph.D. at the University of Limoges, where his thesis focused on the interactions between probiotics and host cells. His postdoctoral work spans institutions in France, the USA, and beyond, each contributing valuable insights into microbial-host dynamics and cellular microbiology. At the University of Bordeaux, he developed metabolomic approaches using GC/MS to study microbiota interactions. Later, at the University of Texas Medical Branch, he delved deeper into the effects of probiotics on intestinal homeostasis. Further postdoctoral experiences at the University of Clermont Auvergne involved examining the relationship between E. coli and colorectal cancer. Through these experiences, Dr. Villéger has gained expertise in microbiota research, cell biology, and metabolic analysis, providing a foundation for his ongoing work in the field. His education has provided a strong interdisciplinary framework, integrating microbiology, molecular biology, and toxicology into his research.

Experience:

Dr. Villéger has accumulated extensive experience in both academic and research settings. After earning his Ph.D. in 2014, he completed several postdoctoral positions, with notable work at the University of Bordeaux, where he pioneered metabolomics techniques for microbiota research. His tenure at the University of Texas Medical Branch expanded his focus to the effects of probiotics on intestinal homeostasis. Additionally, his work at the University of Clermont Auvergne involved exploring the connection between microbial interactions and cancer. Since joining the University of Poitiers in 2020 as an Assistant Professor, Dr. Villéger has led several research projects, including investigating the impact of endocrine disruptors on colorectal cancer development. He is also a leader in metabolomics and microbial pathogenesis, with a particular focus on bacteria-host interactions and microbiota modulation. His research has contributed to numerous publications and collaborations with institutions worldwide, showcasing his ability to manage complex research projects.

Research Focus:

Dr. Villéger’s research primarily focuses on bacteria-host interactions, gut microbiota, and cellular microbiology, with a special interest in how microbial populations affect host metabolism. His work integrates metabolomics, a powerful tool for studying metabolic processes, to better understand microbial influence on host cells. Dr. Villéger’s recent studies explore the role of oxidative stress in microbial infections, including Legionella pneumophila’s subversion of host immune defenses during infection. He has also investigated the impact of endocrine disruptors on microbial virulence, providing insights into the potential links between environmental factors and microbial pathogenesis. His contributions to understanding the microbiota-gut-brain axis, particularly in the context of colorectal cancer, emphasize the metabolic changes induced by bacterial interactions. Dr. Villéger’s research aims to identify biomarkers for disease and therapeutic interventions, with a broader goal of advancing precision medicine through a better understanding of the cellular and metabolic processes that underlie microbial-host dynamics.

Publications Top Notes:

  1. Legionella pneumophila subverts the antioxidant defenses of its amoeba host Acanthamoeba castellanii 💥🦠
  2. Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn’s Disease 🔬🧬
  3. Exposure to endocrine disruptors promotes biofilm formation and contributes to increased virulence of Pseudomonas aeruginosa 💧🦠
  4. Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer 🧬🦠
  5. Effect of endocrine disruptors on bacterial virulence 🌿🧪
  6. Proteomic analysis of Acanthamoeba castellanii response to Legionella pneumophila infection 🔬🦠
  7. Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism 🧬🍊
  8. Microbiota medicine: towards clinical revolution 🌍💊
  9. Deletion of cystathionine-γ-lyase in bone marrow-derived cells promotes colitis-associated carcinogenesis 🔬🦠
  10. Prebiotic Isomaltooligosaccharide Provides an Advantageous Fitness to the Probiotic Bacillus subtilis CU1 🍞🦠

Conclusion:

Dr. Romain Villéger is a highly qualified candidate for the Cell Metabolism Award. His research contributions in understanding microbial influence on cellular metabolism and gut health, combined with his innovative approach to metabolomics, make him stand out in the field. His work bridges basic science and potential clinical applications, positioning him as a key figure in the ongoing exploration of microbial and metabolic influences on host physiology. With some expansion into clinical applications and further exploration of new metabolomics techniques, his contributions could significantly impact both scientific knowledge and medical practice.

 

 

 

Wen zhen Ding | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Wen zhen Ding | Cancer Cell Biology | Best Researcher Award

Dr. Wen zhen Ding , Chinese PLA General Hospital , China

Wenzhen Ding is a prominent researcher specializing in liver disease diagnostics and treatment using advanced imaging and thermal ablation technologies. Currently an attending physician at the Fifth Medical Center, PLA General Hospital, and pursuing a PhD in Imaging Medicine and Nuclear Medicine at PLA Medical College, Ding has contributed extensively to the field of liver cancer treatment. His work combines ultrasound, magnetic resonance imaging (MRI), and machine learning techniques to optimize thermal ablation procedures for hepatocellular carcinoma (HCC). Ding’s interdisciplinary approach integrates clinical insights with technological innovation, making a significant impact on the medical community. He has actively participated in several high-level research projects, including NSFC-funded initiatives, and has authored numerous publications in leading journals. With a track record of successful research grants and collaborations, Ding is recognized for his leadership in developing cutting-edge diagnostic and therapeutic technologies for liver diseases.

Publication Profile:

Scopus

Strengths for the Award:

  1. Significant Research Involvement:
    • Wenzhen Ding has been involved in multiple high-impact research projects, particularly in the field of liver disease, ultrasound imaging, and liver cancer treatment, which are crucial and high-visibility areas of medical research.
    • As a co-first author and sole first author in several representative publications, they have contributed extensively to groundbreaking research, such as the application of ultrasound contrast imaging and thermal ablation in liver cancer treatment.
  2. Key Contributions to Liver Cancer Research:
    • Ding’s focus on intelligent diagnostic systems for liver cancer, including research on ultrasound-guided microwave ablation and decision-making models, demonstrates a clear commitment to improving clinical outcomes in hepatocellular carcinoma (HCC) management.
    • The research on “Percutaneous microwave ablation versus robot-assisted hepatectomy for early hepatocellular carcinoma” showcases their leadership in advancing new treatment modalities.
  3. International Collaboration and Publication:
    • Ding’s work spans several highly regarded journals, with notable publications in International Journal of Hyperthermia, European Radiology, and Liver Cancer. The citation impact also indicates that the research has been influential in the academic community.
    • Their contributions to international conferences, such as the IEEE International Conference on Development and Learning, suggest an ability to communicate and collaborate globally.
  4. Innovative Use of Technology in Medicine:
    • The development of intelligent auxiliary systems for ablation parameters and machine learning models demonstrates a forward-thinking approach to integrating technology with medical treatment.
    • The application of MRI and ultrasound for liver tumor tracking and treatment decision-making is highly innovative and adds significant value to the field.

Areas for Improvement:

  1. Broader Research Horizons:
    • While Ding’s focus on liver cancer and ultrasound technology is commendable, expanding research into other fields or interdisciplinary approaches could further enrich their profile and lead to more diverse applications of their work.
  2. Clinical Translation:
    • Although there is a clear emphasis on technological innovations, there might be a stronger emphasis needed on real-world clinical applications and trials. Bridging the gap between research and actual clinical practice, while also addressing any potential regulatory hurdles, could strengthen the impact of Ding’s research.
  3. Collaboration in Broader Multi-Institutional Studies:
    • Participating in or leading larger, multi-institutional studies that validate findings across diverse populations could elevate the reliability and generalizability of the research outcomes.

Education:

Wenzhen Ding holds a Bachelor’s degree in Clinical Medicine from the Air Force Medical University (2009-2014). His academic journey continued with a Master’s degree in Imaging Medicine and Nuclear Medicine from PLA Medical College (2019-2022). Currently, he is pursuing a PhD in the same field at PLA Medical College, expected to be completed in 2025. His educational foundation has been a crucial element in his expertise in liver disease diagnostics and therapy, particularly in the integration of imaging technologies like ultrasound and MRI with thermal ablation. Throughout his studies, Ding has exhibited exceptional research capabilities, focusing on improving clinical outcomes for patients with liver cancer. His scholarly work has been supported by national funding bodies, including the National Natural Science Foundation of China (NSFC), which recognizes his contributions to the evolving field of medical imaging and ultrasound-guided therapies.

Experience:

Dr. Wenzhen Ding has over a decade of clinical and research experience in the field of ultrasound medicine and liver disease treatment. He began his career as a physician at the PLA 66429th Army Hospital in the Ultrasound Department from 2014 to 2019, where he developed expertise in diagnostic imaging and interventional procedures. Since 2019, he has served as an attending physician at the Fifth Medical Center, PLA General Hospital, specializing in ultrasound-guided treatments for liver cancer. Dr. Ding’s research career has been focused on applying advanced imaging techniques, including ultrasound and MRI, in conjunction with artificial intelligence, to enhance the precision of ablation therapies for hepatocellular carcinoma (HCC). He is also the lead researcher in a key project aimed at developing intelligent systems for ablation decision-making in liver cancer. Ding’s work has contributed to numerous publications in renowned journals and has earned him significant recognition in the medical community.

Awards and Honors:

Dr. Wenzhen Ding has earned several prestigious awards and honors for his exceptional contributions to the medical field, particularly in the areas of liver cancer diagnosis and treatment. He has received funding from the National Natural Science Foundation of China (NSFC) for his innovative research in ultrasound-guided liver cancer therapies. His research work has been highly regarded and has earned him recognition as a leading researcher in the field. Additionally, Ding’s clinical expertise in ultrasound and thermal ablation technologies has been acknowledged with multiple academic and professional awards, including honors from various medical institutions and peer-reviewed journals. His collaborative work with leading experts in the field has further cemented his reputation as a key contributor to the development of more effective diagnostic and therapeutic strategies for liver diseases. Dr. Ding is also a frequent speaker at international conferences, where he shares his findings on optimizing liver cancer treatment and improving patient outcomes.

Research Focus:

Dr. Wenzhen Ding’s primary research focus is on enhancing the treatment of liver diseases, particularly hepatocellular carcinoma (HCC), through innovative diagnostic and therapeutic technologies. His work centers around combining advanced ultrasound and magnetic resonance imaging (MRI) techniques with machine learning and artificial intelligence to optimize liver cancer treatments. Ding’s research aims to improve the accuracy and effectiveness of thermal ablation therapies, a common method for treating liver tumors, by using real-time imaging to guide the procedure and predict therapeutic outcomes. Another major aspect of his research involves the development of intelligent systems that assist in clinical decision-making for liver cancer treatment, focusing on personalizing therapy to individual patient needs. He is also exploring how to predict and prevent tumor recurrence after thermal ablation and how factors such as liver cirrhosis and tumor location can affect treatment success. Ding’s work is instrumental in bridging the gap between clinical practice and technological innovation in liver disease treatment.

Publications Top Notes:

  • “Intelligent Auxiliary System for Ablation Parameters of Hepatocellular Carcinoma Based on Ultrasound Contrast Imaging” 📄💡
  • “Automated Parameters Prediction for Microwave Thermal Ablation of Liver Tumor with Ultrasound Image” 📊🔬
  • “Long-term Liver Lesion Tracking in Contrast-Enhanced Ultrasound Videos via a Siamese Network with Temporal Motion Attention” 💻📅
  • “Analysis of the Therapeutic Effect of Ultrasound-Guided Microwave Ablation in the Treatment of Liver Metastasis from Breast Cancer” 🩺🔬
  • “The Influence of Peritumoral Parenchyma on Local Tumor Progression of Hepatocellular Carcinoma after Thermal Ablation: A Retrospective Multicenter Study” 🔬🧠
  • “Peripheral Immune Factors Aiding Clinical Parameter for Better Early Recurrence Prediction of Hepatocellular Carcinoma after Thermal Ablation” 🧬🧪
  • “Are All Local Tumor Progressions of HCC Related to Thermal Ablation? A Study of the Causes and Classification of Local Tumor Progression” 🔍🩻
  • “A Hybrid Machine Learning Model Based on Semantic Information Can Optimize Treatment Decision for Naïve Single 3-5-cm HCC Patients” 🤖💻
  • “Spatial Distribution Pattern of Local Tumor Progression Analysis after Microwave Ablation of Hepatocellular Carcinoma Based on 3D MRI” 🧠📷

Conclusion:

Wenzhen Ding is a highly deserving candidate for the Best Researcher Award, demonstrating exceptional leadership in research, significant academic contributions, and impactful innovations in liver disease treatment. Their ability to leverage cutting-edge technology and their commitment to advancing clinical practices sets them apart. While there are opportunities to expand the scope of their work, their current body of research showcases promise and considerable impact in their field.

 

 

 

Majid Sadeghizadeh | Cell Structure Analysis | Cellular Imaging Award

Published on by Cell Biologist

Prof. Majid Sadeghizadeh | Cell Structure Analysis | Cellular Imaging Award

Prof. Majid Sadeghizadeh , tarbiat modares univercity , Iran

Dr. Majid Sadeghizadeh is a distinguished Professor and Head of the Genetics Department at Tarbiat Modares University (TMU), Iran. With a Ph.D. in Molecular Biology from Paris, he specializes in Molecular Genetics, with a particular focus on infectious diseases, cancer therapy, and nanobiotechnology. Dr. Sadeghizadeh has contributed extensively to molecular diagnosis, including human Herpes viruses, HIV, and COVID-19, as well as the design of nanomaterials for drug delivery and cancer treatment. His work in cell imaging using carbon dots is groundbreaking. He has published over 200 papers, earned a citation index of 8337, and holds an H-index of 50. Dr. Sadeghizadeh is also the author of several books and has been involved in patenting innovative nano-based products. As an academic leader, he collaborates with global institutions, and his research influences cancer therapy, bioimaging, and drug delivery technologies.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Majid Sadeghizadeh has made significant contributions to the field of cellular imaging, particularly through his research on the application of carbon dots prepared from biomaterials for cell imaging. His expertise in nanobiotechnology, including the design of advanced nanomaterials such as Nano Curcumin and Nano Milk Thistle for cancer therapy and drug delivery, has led to groundbreaking advancements in imaging techniques and therapeutic monitoring. His multi-disciplinary approach, combining molecular biology with nanotechnology, enhances the capabilities of imaging technologies, offering more precise and effective solutions for disease detection and treatment. Additionally, his extensive publication record and high citation index underscore his impact on the scientific community, particularly in areas related to bioimaging and cancer research.

Areas for Improvement:

While Dr. Sadeghizadeh’s work is notable, expanding his research on the integration of imaging techniques with clinical applications could further enhance the translation of his innovations into therapeutic settings. This could involve collaborations with clinical researchers to validate his imaging methods in real-world medical applications, potentially focusing on early detection and personalized medicine.

Education:

Dr. Majid Sadeghizadeh earned his Ph.D. in Molecular Biology from Paris, where he focused on the transcription and replication of human herpesviruses. His educational journey laid the foundation for his groundbreaking contributions to molecular genetics, particularly in infectious diseases, cancer therapy, and nanobiotechnology. He has furthered his academic expertise through numerous collaborations with international research institutions, strengthening his focus on molecular diagnostics and the application of nanomaterials in medicine. His training in Paris instilled in him a strong commitment to advancing molecular genetics research, which continues to drive his innovative work at Tarbiat Modares University. He has guided numerous graduate students and postdoctoral fellows, and his own research has been pivotal in enhancing the scientific understanding of viral infections and cancer treatment. His academic achievements are complemented by his publications, patents, and ongoing contributions to the scientific community.

Experience:

Dr. Majid Sadeghizadeh brings over two decades of experience as a Professor and Head of the Genetics Department at Tarbiat Modares University (TMU), Iran. Throughout his career, he has focused on molecular genetics, developing diagnostic tools for infectious diseases such as Herpes Simplex Virus (HSV), HIV, and COVID-19. His research also extends into nanobiotechnology, where he has made significant strides in creating nanomaterials for cancer therapy and drug delivery. As a principal investigator in the Genetics and Nanobiotechnology Department at TMU, he has led multiple research projects that bridge the gap between molecular biology and practical medical applications. Dr. Sadeghizadeh has published over 200 papers in SCI and Scopus-indexed journals and has contributed to several books on molecular biology and genetic engineering. He has also been involved in various industry projects, such as the industrial production of Nano Curcumin for use as an antioxidant in pharmaceuticals.

Research Focus:

Dr. Majid Sadeghizadeh’s research is at the intersection of molecular genetics, nanobiotechnology, and medical applications. He focuses on the molecular diagnosis of human infectious viruses, such as HSV, HIV, and COVID-19, with an emphasis on improving diagnostic tools and therapeutic strategies. His research in nanobiotechnology aims to design and construct advanced nanomaterials, including Nano Curcumin, Nano Solanine, and Nano Milk Thistle, for targeted cancer therapy and drug delivery. Additionally, Dr. Sadeghizadeh has pioneered the use of carbon dots prepared from biomaterials for cell imaging, advancing the capabilities of non-invasive diagnostics and therapeutic monitoring. His innovative work in these areas has led to the development of novel approaches for drug delivery, cancer treatment, and disease diagnosis. By combining molecular biology with nanotechnology, Dr. Sadeghizadeh’s research continues to push the boundaries of personalized medicine, offering new possibilities for treatment and early detection of diseases.

Publications Top Notes:

  1. 3D Printing of Biocompatible and Antibacterial Silica-Silk-Chitosan-Based Hybrid Aerogel Scaffolds Loaded with Propolis (2024) 🧪
  2. Intelligent guide RNA: dual toehold switches for modulating luciferase in the presence of trigger RNA (2024) 🔬
  3. Inhibition of HIV-1 infection with curcumin conjugated PEG-citrate dendrimer; a new nano formulation (2024) 💉
  4. Synergistic effect of curcumin and tamoxifen loaded in pH-responsive gemini surfactant nanoparticles on breast cancer cells (2024) 💊
  5. Inhibitory effect of dendrosomal-nanocurcumin on Burkitt’s lymphoma cells by reducing EBV lytic gene expression (2024) 💀
  6. Evaluation of the Expression Level of Some Coding and Non-coding Genes in Breast Cancer Samples Based on Bioinformatics and Laboratory Studies (2024) 🧬
  7. Encapsulation of propolis extracted with methylal in the chitosan nanoparticles and its antibacterial and cell cytotoxicity studies (2024) 🌿
  8. MicroRNA-203a inhibits breast cancer progression through the PI3K/Akt and Wnt pathways (2024) 💡
  9. Development of an ostrich-derived single-chain variable fragment (scFv) against PTPRN extracellular domain (2024) 🦢
  10. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme (2024) 🧠

Conclusion:

Dr. Majid Sadeghizadeh is highly deserving of the Cellular Imaging Award due to his pioneering work in carbon dot-based imaging and his broader contributions to nanobiotechnology in cancer therapy and drug delivery. His research is advancing the capabilities of cellular imaging and holds great promise for improving disease diagnostics and treatments. By fostering further integration of his innovations into clinical practices, Dr. Sadeghizadeh can continue to shape the future of personalized medicine and medical imaging.

 

 

 

Palanisamy Vasudhevan | Cellular Stress Response | Best Researcher Award

Published on by Cell Biologist

Dr. Palanisamy Vasudhevan | Cellular Stress Response | Best Researcher Award

Dr. Palanisamy Vasudhevan , Chengdu University of Technology , China

Palanisamy Vasudhevan is a highly accomplished researcher with nine years of experience in environmental science, specializing in soil ecology, phytoremediation, and environmental remediation. Currently a Post-Doctoral Fellow at the State Key Laboratory of Geohazard Prevention and Geoenvironment Protection in Chengdu, China, he has demonstrated expertise in the bioremediation of chlorinated aromatic contaminants, heavy metal pollution, and the utilization of biocatalytic enzymes in various applications. He has contributed significantly to understanding the environmental risks posed by heavy metals and their impact on ecosystems, particularly in agricultural contexts. With a strong foundation in plant biotechnology, biochemistry, and environmental risk analysis, Vasudhevan has published multiple articles in high-impact journals. His work reflects his dedication to addressing critical environmental challenges through innovative research and sustainable solutions.

Publication Profile:

Scopus

Strengths for the Award:

Palanisamy Vasudhevan is a well-rounded researcher with a proven track record of over nine years in the fields of environmental science, biochemistry, and bioremediation. His research focuses on addressing critical global environmental issues, such as chlorinated aromatic contaminant degradation, soil ecology, phytoremediation, heavy metal assessment, and health risk analysis.

His post-doctoral research on organic ligand-assisted Fe(II)-activated persulfate for enhanced degradation of contaminants in soil and water demonstrates innovative approaches to environmental remediation. With multiple high-impact publications in reputable journals like the International Journal of Biological Macromolecules and the Journal of Hazardous Materials Advances, Vasudhevan has contributed significantly to advancing knowledge in biocatalysis and environmental health. Furthermore, his expertise in phytoremediation and cadmium accumulation in rice makes him a leader in applying plant biotechnology for solving soil contamination issues.

His ability to secure fellowships, like the Junior Research Fellowship and University Research Fellowship, shows his leadership potential and commitment to excellence in research.

Areas for Improvement:

While Vasudhevan has an impressive research profile, expanding his research collaborations internationally and diversifying his research themes could further enhance his impact. Engaging in interdisciplinary research with experts in fields like environmental engineering, public health, and policy-making could broaden the scope of his contributions and translate his work into real-world solutions. Additionally, focusing on developing practical, scalable methods for large-scale remediation projects could help bridge the gap between research and implementation.

Education:

Palanisamy Vasudhevan pursued his academic journey with a strong emphasis on environmental science and biochemistry. He is currently a Post-Doctoral Fellow in Geological Engineering at the State Key Laboratory of Geohazard Prevention and Geoenvironment Protection, Chengdu University of Technology, China. He earned his Ph.D. in Environmental Science from Periyar University, India (2014-2022), focusing on cadmium and heavy metal accumulation in paddy soils and rice varieties. Before his doctoral work, he completed his Master’s and Bachelor’s degrees in Biochemistry from K.S. Rangasamy College of Arts & Science, Tamil Nadu, India, where he achieved high academic excellence (82.08% in MSc and 71.5% in BSc). This extensive academic background provides Vasudhevan with a robust understanding of biochemistry, environmental science, and their applications in solving global ecological problems.

Experience:

Palanisamy Vasudhevan’s academic and professional experiences span several research fields, including bioremediation, soil ecology, and heavy metal assessment. As a Post-Doctoral Fellow, he has worked on organic ligand-assisted Fe(II)-activated persulfate for enhanced degradation of chlorinated aromatic contaminants in soil and water, contributing to sustainable environmental cleanup. His doctoral research focused on the accumulation of cadmium and other heavy metals in paddy soils and rice, contributing valuable insights into soil pollution and its impact on food security. Additionally, Vasudhevan has three years of experience as a Junior Research Fellow (JRF) in phytoremediation, studying metal-tolerant plants in industrial clusters. Throughout his career, Vasudhevan has demonstrated leadership, commitment, and an ability to secure research fellowships and grants, strengthening his research profile. His interdisciplinary expertise positions him as a researcher dedicated to solving environmental issues with sustainable, innovative solutions.

Research Focus:

Palanisamy Vasudhevan’s research primarily addresses environmental contamination, focusing on heavy metals, chlorinated aromatic compounds, and the role of phytoremediation in detoxifying polluted ecosystems. His recent work involves enhancing soil and water remediation processes using organic ligand-assisted Fe(II)-activated persulfate, an advanced oxidative technology for degrading persistent pollutants. He also investigates the bioremediation potential of metal-tolerant flora, contributing to sustainable solutions for cleaning up contaminated industrial sites. Vasudhevan’s doctoral research explored cadmium and heavy metal accumulation in agricultural soils, with an emphasis on food safety and ecological risk assessment in rice cultivation. Furthermore, his work in biocatalysis and plant biotechnology explores innovative applications of enzymes for environmental clean-up and waste management. Through his interdisciplinary research, Vasudhevan aims to advance environmental sustainability by mitigating the effects of pollution, improving ecosystem health, and ensuring food security, particularly in contaminated agricultural regions.

Publications Top Notes:

  1. Biocatalytic enzymes in food packaging, biomedical, and biotechnological applications: A comprehensive review 🧬🧪 (2025)
  2. Enhanced biocatalytic laccase production using agricultural waste in solid-state fermentation by Aspergillus oryzae for p-chlorophenol degradation 🌿💡 (2024)
  3. Organic Ligand-Assisted Fe (II)-Activated Persulfate for Enhanced Degradation of Chlorinated Aromatic Contaminants in Soil Remediation 🌍🧪 (2024)
  4. Pollution assessment, ecological risk and source identification of heavy metals in paddy soils and rice grains from Salem, South India 🌾⚖️ (2025)
  5. Uptake and translocation of cadmium and trace metals in common rice varieties at different growth stages 🌱⚙️ (2024)
  6. Pollution assessment and source apportionment of metals in paddy field of Salem, South India 🏞️💧 (2022)

Conclusion:

Palanisamy Vasudhevan is undoubtedly a strong candidate for the Research for Best Researcher Award. His innovative contributions, particularly in environmental remediation and bioremediation, showcase his potential to make lasting impacts on global environmental sustainability. His academic and research achievements highlight his dedication and leadership in the scientific community. With minor enhancements to his collaborative and application-focused work, Vasudhevan could further elevate his role as a leading researcher in environmental sciences.

 

 

 

Ting Wang | Blood brain barrier | Best Researcher Award

Published on by Cell Biologist

Dr. Ting Wang | Blood brain barrier | Best Researcher Award

Dr. Ting Wang , Guangzhou First People’s Hospital , China

Dr. Wang Ting, born on September 16, 1989, is an accomplished attending physician in the Department of Neurology at Guangzhou First People’s Hospital. She earned her Doctor of Medicine degree and actively mentors master’s students specializing in clinical practice. With a robust background in neurology, Dr. Wang has developed expertise in managing Parkinson’s disease, movement disorders, and cognitive disorders. Her innovative research spans across clinical treatments, including deep brain stimulation, botulinum toxin injections for dystonia, and studying intracranial infections. Dr. Wang is an esteemed member of several key medical committees in Guangdong, focusing on neurological diseases and geriatric healthcare. With a passion for improving patient outcomes and advancing research, Dr. Wang has made significant contributions to the field, with multiple publications in high-impact journals.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Wang Ting is highly deserving of the Best Researcher Award due to her significant contributions to the field of neurology. Her extensive expertise in clinical practice and research, particularly related to Parkinson’s disease, movement disorders, cognitive disorders, and deep brain stimulation, places her at the forefront of neurological science. Her work is not only clinically impactful but also academically rigorous, evidenced by multiple high-impact publications in renowned journals. Dr. Wang’s research spans several crucial areas in neurology, including botulinum toxin therapy, brain stimulation, and cognitive disorder treatments. Furthermore, her involvement in prestigious committees and mentorship roles highlights her leadership in the field, as she actively shapes the next generation of neurologists. The depth and breadth of her research, along with her commitment to improving patient outcomes, demonstrate her outstanding qualifications for this award.

Areas for Improvement:

While Dr. Wang’s research is already of the highest caliber, there are always opportunities for growth in a dynamic field like neurology. Expanding her collaborative efforts with international research teams could further enhance the global reach and impact of her work. Additionally, Dr. Wang may benefit from increasing her involvement in interdisciplinary studies, particularly exploring the intersection between neuroscience and other emerging fields like genetics, artificial intelligence, and personalized medicine. Integrating cutting-edge technologies such as AI-driven diagnostics or biomarkers could open new avenues for her research, allowing for deeper insights into the complexities of neurological diseases.

Education:

Dr. Wang Ting completed her Doctor of Medicine (MD) degree, showcasing her commitment to advancing medical knowledge and patient care. As a medical professional, she has continually pursued academic excellence and deepened her clinical expertise, particularly in neurology. Over the years, she has balanced clinical practice with research, helping to guide the future of treatments for movement disorders, cognitive impairments, and neurological diseases. In addition to her medical degree, Dr. Wang is actively involved in the mentorship of master’s students specializing in clinical practice. This role allows her to impart her knowledge, inspire the next generation of neurologists, and encourage academic growth within the medical community. Dr. Wang’s continuous educational development and contributions to her field demonstrate a strong dedication to advancing neurology, particularly in complex areas like Parkinson’s disease and deep brain stimulation.

Experience:

Dr. Wang Ting has a well-rounded career in neurology, having served as an attending physician at Guangzhou First People’s Hospital, one of the leading medical institutions in China. Her role includes diagnosing and treating complex neurological conditions such as Parkinson’s disease, movement disorders, and cognitive impairments. With hands-on expertise in deep brain stimulation and botulinum toxin therapy, Dr. Wang has successfully applied her knowledge in clinical settings, directly impacting patient outcomes. She is also a mentor for master’s students, guiding future neurologists in clinical practice and research. Dr. Wang’s extensive involvement in medical committees, such as the Hypertensive Cerebral Hemorrhage Subcommittee and the Parkinson’s Disease Committee of Guangdong, highlights her leadership in advancing the field of neurology. Additionally, her participation in national and international research projects has further bolstered her experience in both clinical and academic domains.

Research Focus:

Dr. Wang Ting’s research spans a variety of crucial areas in neurology, focusing particularly on Parkinson’s disease, movement disorders, and cognitive impairments. One of her key research areas includes the comprehensive management of Parkinson’s disease, including preoperative screening and postoperative programming for deep brain stimulation. She has conducted significant research on botulinum toxin type A injection therapy for focal dystonia. Dr. Wang is also engaged in understanding the pathophysiology of intracranial infections and cognitive disorders, alongside her work in the basic research of neurological diseases. Her research seeks to develop better therapeutic strategies and diagnostics to improve patient outcomes in these areas. Dr. Wang’s work is further exemplified by her involvement in studying vascular, inflammatory, and metabolic risk factors related to dementia in Parkinson’s disease patients with comorbid type 2 diabetes. Through her research, Dr. Wang aims to bridge the gap between clinical practice and scientific advancements in neurology.

Publications Top Notes:

  1. Disease spectrum and prognostic factors in patients treated for tuberculous meningitis in Shaanxi province, China 🧠🔬
  2. Downregulation of platelet-derived growth factor receptor β in pericytes increases blood-brain barrier permeability and significantly enhances α-synuclein in a Parkinson’s Disease 3D cell model 🧪🧑‍🔬
  3. Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus 💔🧠
  4. High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China 💉🌍
  5. Sub-optimal specificity of modified Ziehl-Neelsen staining for quick identification of tuberculous meningitis 🔬🦠
  6. Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson 🧬⚡
  7. Clinical manifestations and changes in cerebrospinal fluid cytology of patients with meningeal carcinomatosis 🧪💀
  8. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma 🧠🩺
  9. Translation of the headache chapter in the 19th edition of Harrison’s Principles of Internal Medicine 📖👩‍⚕️

Conclusion:

Dr. Wang Ting stands out as an exemplary researcher and clinician in the field of neurology, with a strong track record of groundbreaking research and significant contributions to the understanding and treatment of neurological disorders. Her comprehensive approach to clinical practice, mentorship, and research positions her as an invaluable asset to the field. With her dedication to improving patient care and advancing scientific understanding, Dr. Wang Ting is undoubtedly a strong candidate for the Best Researcher Award.